中国机器人辅助胸腔镜手术的初步经验。
Initial experience of robot-assisted thoracoscopic surgery in China.
作者信息
Huang Jia, Luo Qingquan, Tan Qiang, Lin Hao, Qian Liqiang, Lin Xu
机构信息
Clinical Centre for Pulmonary Tumour, Shanghai Jiaotong University Affiliated Shanghai Chest Hospital, People's Republic of China.
出版信息
Int J Med Robot. 2014 Dec;10(4):404-9. doi: 10.1002/rcs.1589. Epub 2014 Apr 29.
BACKGROUND
The objective of this study was to evaluate the safety and feasibility of robot-assisted thoracoscopic surgery (RATS).
METHODS
From May 2009 to May 2013, 48 patients with intrathoracic lesions underwent RATS with the da Vinci® Surgical System was reported (11 lobectomies, 37 mediastinal tumour resections).
RESULTS
RATS was successfully and safely completed in all 48 patients. Conversion of the operation to open surgery was not needed in any patient. The average operation time was 85.9 min, average blood loss 33 ml, and average hospital stay 3.9 days. No patient required blood transfusion. The only recognized adverse event was the development of a bronchopleural fistula in one patient.
CONCLUSIONS
RATS appears feasible and safe in thoracic surgery. More investigation will be needed in order to determine its possible long-term benefits and cost effectiveness.
背景
本研究的目的是评估机器人辅助胸腔镜手术（RATS）的安全性和可行性。
方法
报告了2009年5月至2013年5月期间，48例胸腔内病变患者使用达芬奇®手术系统接受机器人辅助胸腔镜手术的情况（11例肺叶切除术，37例纵隔肿瘤切除术）。
结果
所有48例患者均成功、安全地完成了机器人辅助胸腔镜手术。无一例患者需要转为开胸手术。平均手术时间为85.9分钟，平均失血量为33毫升，平均住院时间为3.9天。无患者需要输血。唯一公认的不良事件是1例患者发生支气管胸膜瘘。
结论
机器人辅助胸腔镜手术在胸外科手术中似乎是可行和安全的。为了确定其可能的长期益处和成本效益，还需要进行更多的研究。
Zotero 插件